THE INSIDES
LIVE

Serial Number

79294155

Owner

THE INSIDES COMPANY LIMITED

Attorney

Molly Buck Richard

Filing Date

Jul 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

THE INSIDES Trademark

Serial Number: 79294155 • Registration: 6495567

THE INSIDES is a trademark filed by THE INSIDES COMPANY LIMITED on July 16, 2020. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

THE INSIDES COMPANY LIMITED (2 trademarks)

VCFO Group Ltd

Entity Type: 99

Trademark Details

Filing Date

July 16, 2020

Registration Date

September 28, 2021

Published for Opposition

July 13, 2021

Goods & Services

Medical services and surgical services, namely gastrointestinal surgery, gynaecological surgery, colorectal surgery and endoscopies of the gastrointestinal tract; Medical and surgical diagnostic testing, monitoring and reporting services; fitting of prosthetics; medical diagnostic testing, monitoring and reporting services in the fields of medicine related to the gastrointestinal tract; DNA screening for medical purposes, namely, medical DNA and genetic testing for the diagnosis of conditions of the gastrointestinal tract; medical diagnostic testing and reporting services for conditions of the gastrointestinal tract; Collection of human cell or tissue samples for the medical diagnosis of conditions of the gastrointestinal tract; remote patient monitoring services to assist medical professionals in providing medical diagnosis and treatment; medical services, namely, monitoring of losses of intestinal fluid from enterostomies; medical services, namely, monitoring of patient adherence to intestinal re-feeding; medical services, namely, intestinal drug delivery services; medical services, namely, intestinal probiotic delivery services; medical services, namely, intestinal microbiome monitoring

Surgical apparatus and instruments and medical apparatus and instruments for use in surgery; surgical devices for use in drug delivery, namely syringes, hypodermic needles, catheters and cannulas for use in drug delivery; external and implantable medical devices, namely prosthetic devices in the nature of artificial gastrointestinal implants, diagnostic medical devices for diagnosing gastrointestinal disorders and diseases, and devices to control the fluid in and out of stoma; Medical instruments, devices and apparatus for use in diagnostic testing of the gastrointestinal tract; medical devices for use in treating or diagnosing functional gastrointestinal disorders; gastrointestinal implants composed of artificial materials; medical instruments for delivery and retrieval of gastrointestinal implants; medical apparatus, namely, systems for delivery and retrieval of gastrointestinal implants; surgical devices for use with patients with colorectal cancer and other gastrointestinal diseases; surgical implants comprised of artificial materials; surgical instruments and apparatus; medical instruments for interstitial thermotherapy of biological tissue; prosthetic artificial gastrointestinal implants and implants for use in urostomies; medical implants comprised of artificial materials; intravascular implants made from artificial materials; medical devices for placing and securing catheters; catheters; medical devices for use in treating or diagnosing rectal cancer, colon cancer, polyps, fistulas, high output ileostomies, high output fistulas; medical devices to assist in trans-anal surgery; medical devices for intestinal re-feeding; medical devices for intestinal drug deployment, sold empty; medical devices for use in treating or diagnosing gastrointestinal disease

Providing a platform-as-a-service (PaaS) featuring computer software platforms to enable patients and health care providers to interact remotely, health care providers to access and manage patient medical data, patients to receive information and advertising related to their health care, and patients and clinicians to purchase health care products, for digital health care purposes; and medical research services and scientific laboratory services for acquiring, testing and screening data within the framework of continuous health monitoring

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 5, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 11, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 11, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 16, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 16, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 28, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 28, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jul 19, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 13, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 23, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 30, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 23, 2021 GNFN
FINAL REFUSAL E-MAILED
Apr 23, 2021 GNFR
FINAL REFUSAL WRITTEN
Apr 23, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 27, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 27, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 7, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 2, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2020 REPR